Central Asian Research Forum meets online to discuss life after COVID-19
PhD student at Cardiff University Mukhit Kulmaganbetov presented a project on developing a drug and a vaccine against COVID-19 at the Central Asian Research Forum on Sustainable Development and Innovation, which was held online. Kulmaganbetov said that an external membrane of SARS-CoV-2, which is the virus strain that causes COVID-19 disease, can be used as a treatment to combat the novel coronavirus. The forum provides a platform for ambitious researchers from Central Asia to present their action-oriented research projects on sustainable development of the region.
In his opening speech, Ambassador of Kazakhstan to the United Kingdom Erlan Idrissov noted that the current COVID-19 pandemic revealed the problems of the modern world, such as the lack of trust and coordinated actions, as well as a mass disinformation. Idrissov highlighted that because of this, the forum and similar platforms are even more important in terms of discussing the issues related to the life after the pandemic.
For several days, the forum participants discussed online the most relevant topics in modern science and industry. At the forum, PhD students and researchers from leading European and Kazakh universities, such as Nazarbayev University, University College London, Loughborough University, Cardiff University, and University of Manchester presented their cutting-edge ideas and developments in robotics, artificial intelligence, education, healthcare, energy and other fields.
The Central Asian Research Forum, which was supposed to take place this March in London, was held online from 10 to 20 April. The online event was organized by the Kazakhstan PhD Association in the United Kingdom in partnership with the Embassy of Kazakhstan in the UK and the Foundation of the First President of Kazakhstan, reported the Kazakh Foreign Ministry.